Sensitive determination of the human epidermal growth factor receptor 2 (HER2) by immuno-polymerase chain reaction with inductively coupled plasma-mass spectrometry detection

Recent Progress in DNA Hybridization Chain Reaction Strategies for Amplified Biosensing

With the continuous development of DNA nanotechnology, various spatial DNA structures and assembly techniques emerge. Hybridization chain reaction (HCR) is a typical example with exciting features and bright prospects in biosensing, which has been intensively investigated in the past decade. In this Spotlight on Applications, we summarize the assembly principles of conventional HCR and some novel forms of linear/nonlinear HCR. With advantages like great assembly kinetics, facile operation, and an enzyme-free and isothermal reaction, these strategies can be integrated with most mainstream reporters (e.g., fluorescence, electrochemistry, and colorimetry) for the ultrasensitive detection of abundant targets. Particularly, we select several representative studies to better illustrate the novel ideas and performances of HCR strategies. Theoretical and practical utilities are confirmed for a range of biosensing applications. In the end, a deep discussion is provided about the challenges and future tasks of this field.

Prognostic prospect of soluble programmed cell death ligand-1 in cancer management

Aggressive tissue biopsy is commonly unavoidable in the management of most suspected tumor cases to conclusively verify the presence of cancerous cells through histological assessment. The extracted tissue is also immunostained for detection of antigens (tissue tumor markers) of potential prognostic or therapeutic importance to assist in treatment decision. Although liquid biopsies can be a powerful tool for monitoring treatment response, they are still excluded from standard cancer diagnostics, and their utility is still being debated in the scientific community. With a myriad of soluble tissue tumor markers now being discovered, liquid biopsies could completely change the current paradigms of cancer management. Recently, soluble programmed cell death ligand-1 (sPD-L1), which is found in the peripheral blood, i.e. serum and plasma, has shown potential as a pre-therapeutic predictive marker as well as a prognostic biomarker to monitor treatment efficacy. Thus, this review focuses on the emergence of sPD-L1 and promising technologies for its detection in order to support liquid biopsies for future cancer management.

Magneto-controlled aptasensor for simultaneous detection of ochratoxin A and fumonisin B1 using inductively coupled plasma mass spectrometry with multiple metal nanoparticles as element labels

The simultaneous detection of multiple mycotoxins is important for food safety. Here, a magneto-controlled aptasensor for quantitative analysis of ochratoxin A (OTA) and fumonisin B1 (FB1) using inductively coupled plasma mass spectrometry (ICP-MS) with multiple metal nanoparticles as element labels was proposed. Firstly, the OTA aptamer (Apt1) and the FB1 aptamer (Apt2) immobilized on the magnetic beads (MBs) were hybridized with probe DNA1-CdSe quantum dots (pDNA1-QDs) and probe DNA2-Ag nanoparticles (pDNA2-Ag NPs) labels, producing the MBs-Apt1-pDNA1-QDs and MBs-Apt2-pDNA2-Ag NPs conjugates, respectively. Then, the MBs-Apt1-OTA and MBs-Apt2-FB1 conjugates were generated with the addition of targets, resulting the pDNA1-QDs and pDNA2-Ag NPs labels released into the solutions. Finally, the signal intensities of ¹¹¹Cd and ¹⁰⁷Ag were detected by ICP-MS, achieving limits of detection of 0.10 and 0.30 ng mL^-1 for OTA and FB1, respectively. The assay showed high specificity and succeeded in wheat flour. The method provides an ideal model for sensitive analysis of multiple mycotoxins in food samples.